La Rosa Holdings Amends Securities Purchase & Token Right Agreements
Ticker: LRHC · Form: 8-K · Filed: Mar 25, 2026 · CIK: 0001879403
Complexity: moderate
Sentiment: neutral
Topics: material-agreement, amendment, securities-purchase, token-right
TL;DR
**La Rosa Holdings just amended major financial agreements, watch for impact on stock.**
AI Summary
La Rosa Holdings Corp. filed an 8-K on March 25, 2026, to report entering into a Material Definitive Agreement on March 24, 2026. This filing includes an amendment to a Securities Purchase Agreement and a Token Right Amendment, indicating potential changes to previous financial arrangements or equity structures. This matters to investors as it signals a modification in the company's financial commitments or ownership, which could impact future earnings or share value.
Why It Matters
This filing indicates La Rosa Holdings Corp. is modifying key financial agreements, which could affect its capital structure and future financial performance. Investors should understand how these amendments might impact their investment.
Risk Assessment
Risk Level: medium — The filing indicates changes to material definitive agreements, which can introduce new risks or alter existing financial obligations for the company.
Analyst Insight
Investors should review the full text of the EX-10.1 and EX-10.2 exhibits to understand the specific terms and implications of the amended agreements, as these could impact future share value or company obligations.
Key Players & Entities
- La Rosa Holdings Corp. (company) — Filer of the 8-K
- March 24, 2026 (date) — Date of the Material Definitive Agreement
- March 25, 2026 (date) — Filing and Acceptance Date of the 8-K
- 0001879403 (company) — CIK of La Rosa Holdings Corp.
FAQ
What is the primary purpose of this 8-K filing by La Rosa Holdings Corp.?
The primary purpose of this 8-K filing is to report the entry into a Material Definitive Agreement on March 24, 2026, as per Item 1.01.
What specific documents were included as exhibits in this 8-K filing?
The filing included 'FORM OF AMENDMENT, DATED MARCH 24, 2026, TO THE SECURITIES PURCHASE AGREEMENT' (EX-10.1) and 'FORM OF TOKEN RIGHT AMENDMENT, DATED MARCH 24, 2026, TO THE TOKEN RIGHT, DATED N' (EX-10.2).
When was the Material Definitive Agreement entered into?
The Material Definitive Agreement was entered into on March 24, 2026, as stated in Item 1.01 and the exhibit descriptions.
What is the CIK number for La Rosa Holdings Corp.?
The CIK number for La Rosa Holdings Corp. is 0001879403.
What is the business address of La Rosa Holdings Corp.?
The business address of La Rosa Holdings Corp. is 1420 CELEBRATION BLVD STE 200 CELEBRATION FL 34747.
Filing Stats: 1,145 words · 5 min read · ~4 pages · Grade level 13.8 · Accepted 2026-03-25 09:34:04
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value LRHC The Nasdaq Stock Mar
- $250,000,000 — gate original principal amount of up to $250,000,000 (the " Notes "), subject to the satisfa
- $751,220.76 — ther, the " Advisors ") an aggregate of $751,220.76 in deferred fees (1) 20% to pay any out
- $77,000 — ng), including payment of an additional $77,000 in deferred fees to the Advisors due an
- $65,000 — l fees, in an aggregate amount of up to $65,000, payable from the net proceeds from the
Filing Documents
- ea0283321-8k_larosa.htm (8-K) — 32KB
- ea028332101ex10-1.htm (EX-10.1) — 15KB
- ea028332101ex10-2.htm (EX-10.2) — 12KB
- 0001213900-26-033883.txt ( ) — 231KB
- lrhc-20260324.xsd (EX-101.SCH) — 3KB
- lrhc-20260324_lab.xml (EX-101.LAB) — 33KB
- lrhc-20260324_pre.xml (EX-101.PRE) — 22KB
- ea0283321-8k_larosa_htm.xml (XML) — 3KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. SPA Amendment As previously reported in a Current Report on Form 8-K of La Rosa Holdings Corp., a Nevada corporation (the " Company "), filed with the Securities and Exchange Commission (the " SEC ") on November 13, 2025 (the " Prior 8-K "), on November 12, 2025, the Company entered into that Securities Purchase Agreement, as amended, (the " SPA "), with certain institutional investors (the " Investors "), pursuant to which the Company agreed to issue and sell, and the Investors agreed to purchase, among other things, in multiple closings, a new series of senior secured convertible notes of the Company in an aggregate original principal amount of up to $250,000,000 (the " Notes "), subject to the satisfaction or waiver of certain closing conditions. On March 24, 2026, the Company and Investors entered into an Amendment to the SPA (the " SPA Amendment ") to amend the SPA and provide that the net proceeds to the Company from any further equity line of credit, equity purchase facility, or at-the-market offering shall be allocated as follows: (i) until such time as the Company has paid to its placement agent and financial advisor (together, the " Advisors ") an aggregate of $751,220.76 in deferred fees (1) 20% to pay any outstanding deferred fees due to the Advisors, (2) 40% to acquire Note Purchased Crypto (as defined in the SPA) as a treasury asset for the Company's balance sheet, and (3) the remaining 40% for general corporate purposes, working capital, acquisitions and other strategic transactions (including, but not limited to, developing next-generation data center infrastructure for AI computing), and (ii) thereafter (1) 50% of the net proceeds shall be used to acquire Note Purchased Crypto as a treasury asset for the Company's balance sheet and (2) the remaining 50% of the net proceeds shall be used for general corporate purposes, working capital, acquisitions and other strategic transactions (including,
01. Financial
Item 9.01. Financial (d) Exhibits. Exhibit No. Description 10.1 Form of Amendment, dated March 24, 2026, to the Securities Purchase Agreement, dated November 12 2025. 10.2 Form of Token Right Amendment, dated March 24, 2026, to the Token Right, dated November 12, 2025. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 25, 2026 LA ROSA HOLDINGS CORP. By: /s/ Joseph La Rosa Name: Joseph La Rosa Title: Chief Executive Officer 2